PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0011860|type 2 diabetes |
| Sentences | 80 |
| PubMedID- 20966915 | Cd36 variants have been associated with type 2 diabetes, features of the metabolic syndrome, and alterations in lipid metabolism. |
| PubMedID- 20197633 | Aim: to clarify the clinical significance of small,dense ldl (sldl) in the metabolic syndrome associated with type 2 diabetes. |
| PubMedID- 23250798 | Objective: to analyze the participation of fatty liver (fl) in the association of metabolic syndrome (ms) with type 2 diabetes and coronary artery calcification (cac). |
| PubMedID- 25054102 | Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 25760026 | Insulin resistance is a common pathological state found in the metabolic syndromeassociated with obesity and type 2 diabetes mellitus, in which target tissues fail torespond properly to physiologic insulin levels (5,7). |
| PubMedID- 22389088 | The metabolic syndrome is often associated with type 2 diabetes mellitus, dyslipidemia, atherosclerosis, hypertension, steatosis of the liver and other organs, as well as hypertension, type 2 diabetes mellitus, and atherosclerosis. |
| PubMedID- 23611470 | The aim of the present study was to investigate the possible associations between dietary energy density (ed) and the metabolic syndrome (mets) in patients with type 2 diabetes. |
| PubMedID- 20153706 | Conclusions: the prevalence of metabolic syndrome in patients with type 2 diabetes in spain is high, even when the low consistency among who, ncep-atp iii and idf criteria is considered. |
| PubMedID- 24171882 | Prevalence of metabolic syndrome in type 2 diabetes mellitus using ncep-atpiii, idf and who definition and its agreement in gwalior chambal region of central india. |
| PubMedID- 22540858 | For the type 2 diabetes (t2d), signs of the metabolic syndrome with high risk for chronic micro- and macro-vascular complications are typical. |
| PubMedID- 23707905 | These results demonstrate that sglt2 selective inhibitor ipragliflozin improves not only hyperglycemia but also diabetes/obesity-associated metabolic abnormalities in type 2 diabetic mice and suggest that ipragliflozin may be useful in treating type 2 diabetes with metabolic syndrome. |
| PubMedID- 21272190 | Aim: we examined the effects of the 11beta-hydroxysteroid dehydrogenase type 1 (hsd1) inhibitor, mk-0916, on the multiple components of the metabolic syndrome (mets) in patients with type 2 diabetes (t2dm) and mets. |
| PubMedID- 25550516 | These findings are important to consider in designing drugs to target type 2 diabetes and other features of the "metabolic syndrome." medical school, boston, ma 02115; school, boston, ma 02215; and. |
| PubMedID- 20305326 | The association between ace i/d polymorphism and metabolic syndrome in type 2 diabetes, was not significant (p=0.204). |
| PubMedID- 21448316 | To identify risk factors associated with metabolic syndrome in patients with type 2 diabetes mellitus according to three diagnostic criteria: world health organization (who), third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults – adult treatment panel iii (ncep-atp iii), and international diabetes federation (idf). |
| PubMedID- 24708638 | Our previous study showed that nc is a good predictor of metabolic syndrome in patients with type 2 diabetes [3]. |
| PubMedID- 20178560 | Patients with chc may develop hepatic steatosis as a consequence of concomitant metabolic syndrome, possibly associated with type 2 diabetes, obesity or increased body mass index (bmi). |
| PubMedID- 22809366 | In addition, fatty liver is a manifestation of metabolic syndrome, and is associated with obesity, type 2 diabetes mellitus (t2dm), and hypertriglyceridemia [11]. |
| PubMedID- 22474593 | At present, little data exist about incidence and the risk factors associated with metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21446088 | Conclusion: administration of metformin in type 2 diabetes with metabolic syndrome decreased cardiovascular risk factors by reducing glycemia, triglycerides, bmi, central obesity and insulin resistance. |
| PubMedID- 26064839 | Recently, adipokine and hepatokine levels have been viewed as important markers in predicting metabolic syndrome in subjects with obesity and type 2 diabetes. |
| PubMedID- 22187640 | In humans, a daily intake of at least 5 g of soluble fiber, particularly from whole-grain foods and fruits, reduced the presence of metabolic syndrome in patients with type 2 diabetes by 54% [65]. |
| PubMedID- 24103901 | Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. |
| PubMedID- 26171246 | Obesity is associated with most of the components of metabolic syndrome, the leading cause of type 2 diabetes. |
| PubMedID- 24816278 | Hepatic manifestations of the metabolic syndrome (hmms) are associated with obesity, type 2 diabetes/insulin resistance, non-alcoholic fatty liver disease (nafld), and progression to non-alcoholic steatohepatitis (nash) [1]. |
| PubMedID- 26097823 | Prevalence of metabolic syndrome in type 2 diabetes mellitus patients. |
| PubMedID- 22723729 | Through these biological mechanisms, the administration of hanp exerted beneficial effects on experimental and clinical acute renal failure.2,3 contrary to these reports, anp was also reported to increase urinary albumin excretion in normoalbuminuric patients with type 1 and type 2 diabetes.15,16 in patients with nephrotic syndrome, plasma anp levels were significantly higher, and the elevated anp enhanced urinary protein excretion. |
| PubMedID- 25648511 | Fibre is the largest component of the seaweed biomass [10,11] and therefore may be present in sufficient amounts when included in the diet to prevent metabolic syndrome associated with obesity, type 2 diabetes and cardiovascular complications [12]. |
| PubMedID- 24695869 | Conclusions: this study established a strong association between low serum testosterone and metabolic syndrome in subjects with both type 2 diabetes and hypertension. |
| PubMedID- 26042596 | Nafld is the hepatic manifestation of metabolic syndrome and is associated with obesity, type 2 diabetes mellitus, dyslipidemia, high blood pressure, insulin resistance and cardiovascular disease [1–3]. |
| PubMedID- 23115071 | Introduction: at present, little data exists about the incidence of, and the risk factors associated with, metabolic syndrome (mets) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23913501 | It became important therefore to study the prevalence of metabolic syndrome in type 2 diabetes in lagos, nigeria as at the present time and compare it with previous prevalence rates as well as rates from other centres as a way of assessing current cardiovascular risk burden in this population. |
| PubMedID- 22075986 | More recently, jurg introduced the critical new concept of the metabolic inflammasome, which senses metabolic stress and contributes to the onset of the metabolic syndrome associated with obesity and type 2 diabetes. |
| PubMedID- 21055836 | Methods: 150 men were recruited from a genetic screening programme for hereditary hemocromatosis (hh) and were tested for type 2 diabetes, other components of the metabolic syndrome, beta cell function (bcf), insulin sensitivity, high-sensitivity c-reactive protein and iron overload. |
| PubMedID- 20827436 | Our patient has a type 2 diabetes with metabolic syndrome defined by an increased waist/hip circumferences more than 0.9, a decreased hdl cholesterol less than 0.4 g/l and diabetes [15]. |
| PubMedID- 25737976 | Aims and objectives: to study the prevalence of the metabolic syndrome in type 2 diabetes mellitus. |
| PubMedID- 20398338 | The data presented indicate that the african grass rat (nile rat) represents a novel model of metabolic syndrome associated with diet-induced type 2 diabetes, expressing developmental growth and nutritional correlates similar to those in humans. |
| PubMedID- 24741576 | In the literature, it has been described that plasma il-6 levels are associated with increased cv risk and observed in sle patients with metabolic syndrome [53] and in patients with type 2 diabetes [44, 54]. |
| PubMedID- 21315688 | Taken together, these results may provide evidence of the therapeutic potential of kr-66344, as a 11beta-hsd1 inhibitor, in obesity and type 2 diabetes patients with metabolic syndrome. |
| PubMedID- 21089455 | [cardiac autonomous neuropathy and metabolic syndrome in patients with type 2 diabetes mellitus]. |
| PubMedID- 23700465 | Obesity and comorbidities (metabolic syndrome, ms, leading to type 2 diabetes mellitus, dm2, cardiovascular disease, cvd, and non-alcoholic fatty liver disease, nafld) is due not only to environmental factors but also to maternal nutrition [1]. |
| PubMedID- 22762010 | Serum levels of c-peptide are associated with the metabolic syndrome in patients with type 2 diabetes and in diabetic patients with nephropathy and vascular disease [37]. |
| PubMedID- 21842146 | The primary etiology of the metabolic syndrome in type 2 diabetes is chronic overnutrition resulting in insulin resistance, abdominal obesity, hyperinsulinemia, and lipotoxicity. |
| PubMedID- 25435604 | Conclusion: our study suggests that diabegon could be included as a preventive treatment in metabolic syndrome subjects with type 2 diabetes especially for long term treatment as it efficiently shows anti-hyperglycemic and anti-lipidemic effects with no adverse impacts on the liver and kidney. |
| PubMedID- 20695946 | Raised plasma urotensin ii in type 2 diabetes patients is associated with the metabolic syndrome phenotype. |
| PubMedID- 21730222 | Objective: to investigate possible associations of dietary glycemic index (gi) and fiber content with metabolic syndrome (mets) in patients with type 2 diabetes. |
| PubMedID- 20823099 | Of significance in the zucker diabetic fat rat, a model of type 2 diabetes associated with the metabolic syndrome, ebselen improved endothelial dysfunction and renal insufficiency (21,22). |
| PubMedID- 20927114 | Therefore, we focused on the spontaneously hypertensive corpulent rat (shr/n-cp), a model with type 2 diabetes, obesity and features of the metabolic syndrome to characterize retinal changes at a structural and functional level. |
| PubMedID- 24589612 | Objective: to study the correlation between adipocytokines levels and metabolic syndrome (ms) in patients with newly diagnosed type 2 diabetes mellitus (t2dm). |
| PubMedID- 22755342 | Metabolic syndrome in type 2 diabetes: comparison of who, modified atpiii & idf criteria. |
Page: 1 2